Noticias y Actividades de NTx Bio

Ver el organigrama con sus 25 ejecutivos principales

Biografías más buscadas en NTx Bio

• Joan Haab, Chief Executive Officer and Director
• David Seldin, Director
• Thomas Nickoloff, Director

Recientes movimientos de ejecutivos en NTx Bio

• Joan Haab que ha sido Chief Operations Officer, ha ascendido a Chief Executive Officer and Director  (noticia publicada el 8 de enero de 2026).
• James Coffin, Chief Executive Officer and Director, ha dejado la empresa  (noticia publicada el 8 de enero de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en NTx Bio.

NTx Bio tiene 2.428 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).

Popular M&A news in Biotecnología

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado el 17 de julio de 2026).
• GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado el 15 de julio de 2026).

Otros contactos sugeridos en el sector Biotecnología

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer en Inceptive
• Jan Van de Winkel - President and Chief Executive Officer en Genmab
• Robert Gould - Board Member en Fulcrum Therapeutics

Saber más sobre el sector Biotecnología

Últimos comunicados de prensa de NTx Bio

• NTx Bio Appoints Dr. Joan Haab as Chief Executive Officer
• NTx Appoints Veteran Corporate Strategist Dave Johnson to Board of Directors
• NTx Expands Scientific Advisory Board with Appointment of RNA Biology Pioneer Dr. Jeff Coller
• News (3)
• Governor Abbott Announces NTxBio Facility In Plano
• NTx Establishes Scientific Advisory Board with Distinguished Leaders in Oncology
• NTx Appoints Seasoned Biotech Executive Joan Haab as Chief Operations Officer
• NTx Welcomes Accomplished Government Industry Executive William Doak as Vice President of Global Government Programs
• NTx Announces Full Commercial Availability of NTxscribe to Broadly Enable RNA Therapies
• NTx Secures $15M in Venture Debt from J.P. Morgan to Fuel Expansion of Next-Generation Biomanufacturing Solutions
• View more press releases Close

Redes sociales sobre NTx Bio

• NTx Bio en Wikipedia, Google News y Yahoo Finance
• NTx Bio en LinkedIn, Twitter y YouTube